Pink Sheet Podcast: Pharma Gets Democratic Senate, Slow COVID-19 Vaccinations, 2020 CDER Approvals
Executive Summary
Pink Sheet reporters and editors consider the implications of a Democratic Congress for the pharma industry, ongoing problems with slow coronavirus vaccination rates, and the high CDER novel approval count in 2020.
You may also be interested in...
Pandemic Perspectives: EU/UK Coronavirus Vaccine And Treatment Progress At A Glance
The EU and the UK are going their own way when it comes to making COVID-19 vaccines and treatments available. The European Commission has chosen the full conditional marketing authorization path, while the UK, no longer a member of the EU, is taking the temporary authorization route.
Pink Sheet Podcast: Pre-Announced FDA Inspections, Vaccine Safety, On-Time Application Decisions
Pink Sheet reporters and editors consider the impact of pre-announced domestic inspections, as well as look at the various COVID-19 vaccine safety monitoring programs and new data on application decisions during the pandemic.
Pink Sheet Podcast: A Year Of The COVID-19 Pandemic, When Will Biden Nominate An FDA Commissioner?
Pink Sheet reporters and editors discuss the impact of the COVID-19 pandemic on pharma and the FDA and consider former commissioners’ pleas for President Biden to nominate a permanent agency commissioner.